Both in Pharmaceuticals
RenovoRx vs Clene
Over the past year RNXT returned +14.7% and CLNN returned −69.4%; their daily moves had a correlation of 0.08.
RNXT +14.7% CLNN −69.4%Growth of $1, one year, split-adjusted
| Metric | RNXT | CLNN |
|---|---|---|
| Price | $1.25 | $3.67 |
| Market cap | $56.4M | $52.2M |
| Today | −6.01% | −4.18% |
| 1 month | −20.9% | −10.0% |
| 6 months | +41.2% | −54.6% |
| Year to date | +48.8% | −37.5% |
| 1 year | +23.2% | −63.3% |
| Revenue growth (YoY) | +115.4% | +233.3% |
| Gross margin | 84.3% | 60.0% |
| Net margin | −320.2% | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | 28.5× | 264.8× |
| Net cash | $9.5M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 108.7% | 82.0% |
| Short % of float | 2.0% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).